PathMaker Neurosystems Inc. ( PathMaker Neurosystems)

Primary tabs

PathMaker Neurosystems's picture

Management

Contact Address

About PathMaker Neurosystems Inc.

PathMaker Neurosystems Inc. is focused on commercialization of groundbreaking advances in neuromodulation based upon our proprietary non‑invasive applications of Trans-Spinal Direct Current Stimulation (tsDCS) technology for the treatment of paralysis, muscle weakness and spasticity. Our technology is built upon the pioneering work of Prof. Zaghloul Ahmed (CSI/CUNY) and our scientific advisors.

PathMaker Neurosystems press release, blog etc

Mon, 01/12/2026 - 17:27 PathMaker Neurosystems Announces Completion of ALS Early-Feasibility Study of the MyoRegulator Device for Non-Invasive Treatment of ALS
Wed, 12/17/2025 - 17:45 PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Use of the MyoRegulator Neuromodulation Device in ALS For Slowing the Progression of Functional Symptoms
Mon, 07/07/2025 - 16:01 PathMaker Neurosystems Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive Neuromodulation
Mon, 06/02/2025 - 07:04 PathMaker Neurosystems Announces Rhode Island Life Sciences Hub (RILSH) Funding to Establish Operations in Rhode Island
Wed, 03/05/2025 - 19:46 PathMaker Neurosystems Announces Issuance of Three Patents Protecting the Use of Companys Proprietary Neuromodulation Technology in ALS
Tue, 02/04/2025 - 05:57 PathMaker Neurosystems Announces IRB Approval for DoD-funded Clinical Trial of the MyoRegulator Device in ALS
Thu, 06/06/2024 - 01:46 PathMaker Neurosystems Announces $2.16 Million Award from U.S. Department of Defense for ALS Clinical Trial
Mon, 02/07/2022 - 08:43 PathMaker Neurosystems Awarded CERF Medical Electronics Prize for Amyotrophic Lateral Sclerosis
Wed, 10/20/2021 - 22:12 PathMaker Neurosystems Appoints Leading Neurotechnology Expert, John Donoghue, Ph.D., to Board of Directors
Mon, 09/27/2021 - 01:53 PathMaker Neurosystems Announces Completion of Pivotal European Clinical Trial Evaluating MyoRegulator for the Non-Invasive Treatment of Post-Stroke Spasticity
Wed, 07/15/2020 - 00:32 PathMaker Neurosystems Welcomes Healthcare Veteran Terri Bresenham to Board of Directors
Mon, 05/11/2020 - 13:38 PathMaker Neurosystems Appoints Medtech Industry Veteran Hooman Hakami as Chairman of Companys Board of Directors
Thu, 07/25/2019 - 07:43 PathMaker Neurosystems Announces Publication of First Clinical Trial Results for its MyoRegulator Device for Non-Invasive Treatment of Spasticity
Wed, 06/26/2019 - 11:06 PathMaker Neurosystems is Named as Recipient of Frances Top Prize for Innovation
Fri, 05/31/2019 - 15:00 PathMaker Neurosystems Sponsored by NIH to Participate in the Innovation Zone at the 2019 BIO International Convention.
Wed, 05/29/2019 - 15:16 PathMaker Neurosystems Appoints Veteran Healthcare Investor William Mills to Board of Directors
Fri, 02/08/2019 - 00:53 PathMaker Neurosystems Announces Publication of Scientific Paper Establishing First Linkage Between Spasticity and Overexpression of a Specific Neuronal Cotransporter
Wed, 01/09/2019 - 08:20 WeHealth by Servier and PathMaker Neurosystems form partnership for a Breakthrough Non-Invasive Neuromodulation Device for the Treatment of Spasticity
more

InfoBox

HomePagepmneuro.com